Legal Considerations in Specialty Pharmacy: 2025 Updates and Developments in the 340B Program
| ACPE Activity Number: 0204-0000-25-127-H03-P Release Date: June 10, 2025 Expiration Date: June 10, 2028 Activity Type: Application-based CE Credits: 2.0 contact hours (0.20 CEUs) Activity Fee: Free |
Activity Overview
This program will describe the evolving legal and regulatory landscape in specialty pharmacy and the significant implications it has for health-system pharmacies and the patients they serve. Recent developments in the 340B program, including key litigation, legislative initiatives, and contracting trends will be highlighted.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
Learning Objectives
Schedule of Activities
-
Introduction and Announcements
-
Presentation
-
Questions, Answers, and Discussion
Faculty
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
-
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.